-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/TND_0086_04-01-2009.pdf
January 01, 2009 - populations, interventions, comparators, and
outcomes, will be further developed in the refinement phase
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/TND__0355_09-22-2010.pdf
January 01, 2010 - populations, interventions, comparators, and outcomes, will be further developed in
the refinement phase
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/TND_0074_03-10-2009.pdf
January 01, 2009 - populations, interventions, comparators, and outcomes, will be further
developed in the refinement phase
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/TND_0283_03-10-2008.pdf
January 01, 2008 - populations,
interventions, comparators, and outcomes, will be further developed in the refinement phase
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/TND_0030_06-19-2008.pdf
January 01, 2008 - populations,
interventions, comparators, and outcomes, will be further developed in the refinement phase
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/TND_0278_03-10-2008.pdf
January 01, 2008 - populations, interventions,
comparators, and outcomes, will be further developed in the refinement phase
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/TND_0215_01-06-2010.pdf
January 01, 2010 - populations, interventions, comparators, and outcomes, will be further developed
in the refinement phase
-
effectivehealthcare-admin.ahrq.gov/products/chronic-urinary-retention/research-protocol
December 01, 2020 - During the Topic Refinement phase of this project, Key Informants suggested that a review focused on … Key Questions
The draft Key Questions (KQs) developed during the Topic Refinement phase were posted … Blind Method/ (118498)
Single Blind Method/ (17086)
clinical trial/ (476450)
clinical trial, phase … i.pt. (12809)
clinical trial, phase ii.pt. (20505)
clinical trial, phase iii.pt. (7571)
clinical … trial, phase iv.pt. (759)
controlled clinical trial.pt. (85694)
randomized controlled trial.pt.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/05_depression_potential_high_impact_june_2012.pdf
January 01, 2012 - Results
The table below lists the 12 topics for which (1) preliminary phase III data on drugs or phase … Mifepristone for treating PMD is being investigated in one phase III clinical trial. … Reclaim is in phase III trials for MDD with an anticipated
completion date of October 2014; Libra is … also in phase III trials. … Jude Medical is evaluating its Libra
®
DBS system for treatment-resistant depression in the
phase
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pregnancy-horizon-scan-high-impact-1412.pdf
December 01, 2014 - inclusion are those interventions expected to be within 0–3 years of potential diffusion (e.g., in
phase … None of these topics
emerged as eligible for inclusion in this report because preliminary phase III … These topics were ineligible for
consideration in this report because no phase III data were available
-
effectivehealthcare-admin.ahrq.gov/products/prostate-cancer-therapies/protocol
March 01, 2020 - therapy versus active surveillance in men with low-risk prostate cancer (CLIN1001 PCM301): an open-label, phase … Patients With Low-Risk Prostate Cancer Treated With Hypofractionated vs Conventional Radiotherapy: A Phase … 26 (763246)
29 27 and 28 (43063)
30 limit 29 to (clinical trial, all or clinical trial, phase … i or clinical trial, phase ii or clinical trial, phase iii or clinical trial, phase iv or clinical trial
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/prostate-cancer-therapies-protocol_amended110619.pdf
November 02, 2019 - versus active
surveillance in men with low-risk
prostate cancer (CLIN1001 PCM301):
an open-label, phase … Patients With Low-
Risk Prostate Cancer Treated With
Hypofractionated vs Conventional
Radiotherapy: A Phase … 26 (763246)
29 27 and 28 (43063)
30 limit 29 to (clinical trial, all or clinical trial, phase … i or clinical trial, phase ii or clinical trial, phase
iii or clinical trial, phase iv or clinical
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/tethered-spinal-cord-protocol.pdf
July 19, 2023 - Lipomyelomeningocele" OR "tight filum syndrome"
Recruitment: Completed studies
Study Results: All studies
Phase … : Phase 2, Phase 3, Phase 4
ICTRP
No limits
“tethered cord syndrome” OR “tethered spinal cord … lying spinal cord” OR “filum
terminale syndrome OR Lipomyelomeningocele” OR “tight filum syndrome”
Phase … : Phase 2, Phase 3, Phase 4
Cochrane Database of Systematic Reviews
tethered cord syndrome OR tethered
-
effectivehealthcare-admin.ahrq.gov/products/tethered-spinal-cord/protocol
August 01, 2023 - Lipomyelomeningocele" OR "tight filum syndrome"
Recruitment: Completed studies
Study Results: All studies
Phase … : Phase 2, Phase 3, Phase 4
ICTRP
No limits
“tethered cord syndrome” OR “tethered spinal cord” … lying spinal cord” OR “filum terminale syndrome OR Lipomyelomeningocele” OR “tight filum syndrome”
Phase … : Phase 2, Phase 3, Phase 4
Cochrane Database of Systematic Reviews
tethered cord syndrome OR tethered
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pulmonary-horizon-scan-high-impact-1306.pdf
June 01, 2013 - inclusion are those interventions expected to be within 0–4 years of potential diffusion (e.g., in
phase … Results
The table below lists three topics in the system for which (1) preliminary phase III or later … Several phase III trials have been
cosponsored by the Cystic Fibrosis Foundation, of Bethesda, MD. … In a
randomized, double-blind, placebo-controlled, phase III trial, cosponsored by the Cystic Fibrosis … Vertex Pharmaceuticals initiates phase 3 registration
program for VX-770, an oral CFTR potentiator
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pulmonary_hi_impact.pdf
April 01, 2012 - III trials
for pharmaceuticals or biotechnologies or in phase II or a trial with some preliminary … The table below lists the three topics for which (1) preliminary phase III were
available for drugs … , or phase II, III or later data were available for devices; (2) information was
compiled by November … The drug is in several phase III clinical trials cosponsored
by the Cystic Fibrosis Foundation. … Vertex Pharmaceuticals initiates phase 3
registration program for VX-770, an oral CFTR
potentiator
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/treatment-resistant-depression_surveillance.pdf
April 01, 2016 - therapy [CBT or interpersonal therapy [IPT]]) differ in efficacy or effectiveness in
treating acute phase … treatments compare with pharmacological
treatments in efficacy or effectiveness in treating acute-phase … Current Literature Analysis:
• We identified a small phase II RCT examining individuals with MDD who … Tier 3:
A small phase II RCT (n=60) examined
individuals with MDD who had responded to
ECT and … RESULTS: Of 90 MDD patients starting the acute phase, 70% responded and 47% remitted to acute ECT.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/goldstrom.pdf
January 06, 2017 - process and
inclusive of many stakeholders, there needs to be sufficient time for feedback
at each phase
-
effectivehealthcare-admin.ahrq.gov/products/n-1-trials/research-2014
August 01, 2019 - While all of the proposed features should be considered during a project's design phase, only a subset … The end result of the design phase is a schedule of treatment periods with specified treatments and measurements … 1 trials, measurements often consist of questionnaire responses or lab values at the end of a trial phase … Time-series data involve repeated daily or weekly measurements that are taken within a given phase of … of the data presentation (colors, emphasis, and labeling), and a rendering phase.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/vaccines-safety-protocol-130325.pdf
September 18, 2012 - The clinical evaluation of a vaccine typically consists of three phases.8 Phase I studies—which
typically … Phase II studies evaluate the immunogenicity of the
vaccine and provide preliminary estimates on the … Phase III trials provide the information on a vaccine’s safety
and effectiveness that is required to